Top Story

Novel DCB improves Rutherford class, other outcomes at 1 year

Novel DCB improves Rutherford class, other outcomes at 1 year
November 14, 2018
Meeting News

First US patient enrolled in below-the-knee trial for DCB

November 13, 2018
Philips announced that the first U.S. patient has been enrolled in the investigational device exemption trial of its drug-coated balloon designed to treat below-the-knee…
Meeting NewsPerspective

DETOUR I: 18-month results encouraging for percutaneous bypass system

November 9, 2018
LAS VEGAS — A fully percutaneous bypass system using the femoral vein as a conduit benefited patients with long superficial femoral artery lesions at 18 months…
Meeting News

DCB shows benefit at 6 months for below-the-knee lesions

November 8, 2018
LAS VEGAS — Anticipated results of the Lutonix BTK study highlighted superior efficacy and similar safety through 6 months with a drug-coated balloon, compared…
More Headlines »
Meeting News Coverage

VIDEO: New research calls attention to type 2 MI

April 16, 2016
More »
Meeting News

Implant successfully repairs dissections caused by angioplasty

November 7, 2018
LAS VEGAS — An endovascular implant used to repair dissections caused by plain or drug-coated balloons during…
More »